Abdul Mannan: Managing Bleeding in Acquired Haemophilia A – Choosing the Right Haemostatic Strategy
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“In acquired haemophilia A, the best haemostatic agent depends on the patient in front of you.
Acquired haemophilia A is not the moment to admire a prolonged APTT from a distance.
If the patient is bleeding, act early and involve a haemophilia centre.
The new BSH/UKHCDO guideline keeps the message practical:
- Control bleeding first
- Avoid trauma and procedures where possible
- Use rFVIIa, aPCC/FEIBA, or rpFVIII for bleeding patients
- Monitor bypassing agents clinically, not by routine clotting tests
- Use rpFVIII when FVIII measurement can guide treatment
- Start inhibitor eradication with immunosuppression, tailored to risk
The key point?
BSH does not crown one universal winner between FEIBA, rFVIIa, and rpFVIII.
The right choice depends on the bleed, thrombotic risk, anti-porcine FVIII inhibitor status, lab support, access, and local haemophilia centre practice.
FEIBA/aPCC and rFVIIa remain trusted bypassing options. rpFVIII has the practical advantage of measurable FVIII levels, which can be very helpful when the bleeding is severe or the response is unclear.
AHA is rare, but when it appears, it tends to theatre. The platelet count sits there innocently while the APTT does all the shouting.
What drives your first choice in AHA bleeding: thrombosis risk, lab monitoring, local access, or centre protocol?”

Find more posts from Abdul Mannan on Hemostasis Today.
-
Jul 16, 2026, 00:20Mettine Bos: Reflecting on a Fantastic ISTH 2026 in Paris with Team Leiden
-
Jul 16, 2026, 00:19Pierre Grès: Proud to Present My PhD Research at ISTH 2026
-
Jul 16, 2026, 00:19Francis Couturaud: Leela Breton Presents Promising PE Research at ISTH 2026
-
Jul 16, 2026, 00:18Alisa Wolberg: An Honor to Present the Gualtiero Palareti Memorial Plenary Lecture at ISTH 2026
-
Jul 16, 2026, 00:17Edward Lee Carter: What ISTH 2026 Tells Us About the Next Era of Thrombosis Care
-
Jul 16, 2026, 00:17Marc Carrier: Celebrating 25 Years of the Adult Thrombosis Fellowship Program at ISTH 2026
-
Jul 16, 2026, 00:16Nikolaos Kotsiou: The Privilege of Presenting Our Clinic’s Newest Findings at My 1st ISTH 2026
-
Jul 16, 2026, 00:14Empowering the Next Generation of Bleeding Disorders Leaders – WFH
-
Jul 16, 2026, 00:13Wolfgang Miesbach: VOYAGER1 Highlights the Potential of Oral Inno8 at ISTH 2026